Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taiwan-Swiss agreement to speed up trade:

This article was originally published in Clinica

Executive Summary

Speeding up medical device trade between Taiwan and Switzerland is the aim of a newly-inked agreement. A reduction of time-consuming and expensive application procedures is among the advantages of the -Taiwan-Swiss Technical Co-operation in Medical Devices". For example, if a Swiss manufacturing site has already been assessed and approved by a recognised assessment body, Taiwan will not require another assessment of the site. Similarly, if a Taiwanese device has the CE mark, additional inspection of the factory site will not be required. The two markets will also exchange information on device failures. The signing took place at the end of August by Liao Chi-chou (director general, Taiwan Bureau of Pharmaceutical Affairs) and Jost Feer (director, Trade Office of Swiss Industries), overseen by Taiwanese minister of health Hou Sheng-mou.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel